Intervention

SUN-101 50 mcg BID eFlow (CS) nebulizer

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting0

Common conditions3

Lead sponsors shown1

Clinical trials

3 shown

Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPDNCT02347761 · 2015-02-01

Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)NCT02347774 · 2015-02-01

A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPDNCT02276222 · 2014-10-01

Common conditions

COPD2 Chronic Obstructive Pulmonary Disease1 Chronic Obstructive Pulmonary Disease (COPD)1

Leading sponsors

Sunovion Respiratory Development Inc.3

Trial status mix

COMPLETED3

Phase mix

PHASE33

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.